Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
4.709
-0.031 (-0.66%)
Jul 30, 2026, 11:49 AM EDT - Market open
Foghorn Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 28.22 | 30.91 | 22.6 | 34.16 | 19.23 | 1.32 | |
Revenue Growth | 20.08% | 36.75% | -33.83% | 77.63% | 1357.77% | 206.74% |
Gross Profit | 28.22 | 30.91 | 22.6 | 34.16 | 19.23 | 1.32 |
Selling, General & Admin | 26.89 | 27.55 | 28.36 | 32.37 | 30.75 | 21.73 |
Research & Development | 82.1 | 85.47 | 94.53 | 109.69 | 105.62 | 80.33 |
Other Operating Expenses | 5.91 | 4.28 | 2.4 | - | - | - |
Total Operating Expenses | 114.91 | 117.3 | 125.29 | 142.06 | 136.37 | 102.05 |
Operating Income | -85.05 | -86.39 | -102.68 | -107.91 | -117.14 | -100.73 |
Interest Income | 7.8 | 8.75 | 11.9 | 10.88 | 5.68 | 0.06 |
Interest Expense | - | - | - | - | - | -1.91 |
Other Non-Operating Income (Expense) | 1.93 | 3.36 | 4.16 | 2.83 | 2.58 | 3.73 |
Total Non-Operating Income (Expense) | 9.73 | 12.11 | 16.06 | 13.71 | 8.26 | 1.88 |
Pretax Income | -75.32 | -74.28 | -86.62 | -94.2 | -108.88 | -98.85 |
Provision for Income Taxes | - | - | - | -4.23 | - | - |
Net Income | -75.32 | -74.28 | -86.62 | -89.97 | -108.88 | -98.85 |
Net Income to Common | -75.32 | -74.28 | -86.62 | -98.43 | -108.88 | -101.32 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 65 | 63 | 55 | 42 | 42 | 37 |
Shares Outstanding (Diluted) | 65 | 63 | 55 | 42 | 42 | 37 |
Shares Change | 7.80% | 14.72% | 30.79% | 0.92% | 11.89% | - |
EPS (Basic) | -1.16 | -1.18 | -1.58 | -2.34 | -2.62 | -2.73 |
EPS (Diluted) | -1.16 | -1.18 | -1.58 | -2.34 | -2.62 | -2.73 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -87.42 | -86.15 | -101.31 | -119.33 | 192.4 | -53.56 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -1.35 | -1.37 | -1.85 | -2.84 | 4.63 | -1.44 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -301.34% | -279.50% | -454.31% | -315.93% | -609.20% | -7637.15% |
Profit Margin | -266.88% | -240.33% | -383.24% | -263.43% | -566.27% | -7494.62% |
FCF Margin | -309.73% | -278.72% | -448.24% | -349.38% | 1000.63% | -4060.88% |
EBITDA | -82.31 | -83.06 | -99.56 | -104.46 | -113.82 | -97.51 |
EBITDA Margin | -291.62% | -268.71% | -440.50% | -305.83% | -591.93% | -7392.49% |
EBIT | -85.05 | -86.39 | -102.68 | -107.91 | -117.14 | -100.73 |
EBIT Margin | -301.34% | -279.50% | -454.31% | -315.93% | -609.20% | -7637.15% |
Effective Tax Rate | - | 0.00% | 0.00% | 4.49% | 0.00% | 0.00% |